Exact Mass: 374.0146
Exact Mass Matches: 374.0146
Found 128 metabolites which its exact mass value is equals to given mass value 374.0146,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-Hydroxymethyletoricoxib
6-Hydroxymethyletoricoxib is only found in individuals that have used or taken Etoricoxib. 6-Hydroxymethyletoricoxib is a metabolite of Etoricoxib. 6-hydroxymethyletoricoxib belongs to the family of Bipyridines. These are organic compounds containing two pyridine rings linked to each other.
Etoricoxib 1'-N'-oxide
Etoricoxib 1-N-oxide is a metabolite of etoricoxib. Etoricoxib (brand name NUSHIN MASCOT HEALTH SERIES Arcoxia worldwide; also Algix and Tauxib in Italy, Nucoxia in India) is a COX-2 selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) from Merck & Co. Currently it is approved in more than 70 countries worldwide but not in the US, where the Food and Drug Administration (FDA) requires additional safety and efficacy data for etoricoxib before it will issue approval. (Wikipedia)
Iguratimod
C308 - Immunotherapeutic Agent
Sodium calcium edetate
Preservative and sequestrant in foods. Ethylenediaminetetraacetic acid, widely abbreviated as EDTA, is a polyamino carboxylic acid and a colourless, water-soluble solid. Its conjugate base is named ethylenediaminetetraacetate. It is widely used to dissolve limescale. Its usefulness arises because of its role as a hexadentate (six-toothed") ligand and chelating agent Preservative and sequestrant in foods
Paeciloquinone D
bromhexine
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1173
(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol|(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamigra-1(15),2,11(12)-trien-9-ol|<1(15)E,2Z,4S,8R,9S>-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol
1-Hydroxy-2,3,7,8-tetramethoxy-chromeno[5,4,3-cde]chromen-5,10-dion|1-hydroxy-2,3,7,8-tetramethoxy-chromeno[5,4,3-cde]chromene-5,10-dione|3,3,4,4-tetra-O-methylflavellagic acid
3,4,5,6tetrahydroxy-2-(3,4,5-trihydroxyphenoxy)biphenyl
6-Hydroxymethyletoricoxib
4-amino-n-[2-[(2-sulfoxy)ethyl]-sulfonyl]ethyl benzamide,sodium
1,1,1,7,7,7-hexafluoro-2,6-bis(trifluoromethyl)hept-3-ene-2,6-diol
Bis(1-ethyl-3-methylcyclopentadienyl)zirconium dichloride
Bis(1-ethyl-2-methylcyclopentadienyl)zirconium dichloride
Pyrroloquinolinequinone disodium salt
Pyrroloquinoline quinone disodium salt, a redox co-factor, is an anionic, redox-cycling orthoquinone. Pyrroloquinoline quinone disodium salt is isolated from cultures of methylotropic bacteria and tissues of mammals. Pyrroloquinoline quinone disodium salt is an essential nutrient for mammals and is important for immune function[1][2].
acetic acid,4-bromo-6-(2-phenyl-1H-pyrazol-3-ylidene)cyclohexa-2,4-dien-1-one
(1S,2S)-1,2-Bis(4-nitrophenyl)-1,2-ethanediamine dihydrochloride
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide monohydrochloride
Edetate calcium disodium
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants
Magnesium Ascorbate
D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins
4-chloro-1-tosyl-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine
2-[2-[(3-Aminobenzoyl)amino]ethylsulfonyl]ethyl hydrogen sulfate
2,2:5,2'-Terthiophene-5-boronic acid pinacol ester
ethyl 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptanoate
(5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone
ethene,3,3,4,4,5,5,6,6,6-nonafluorohex-1-ene,1,1,2,2-tetrafluoroethene
4-Methylumbelliferyla-L-idopyranosiduronicacidsodiumsalt
(1R,2R)-1,2-BIS(4-NITROPHENYL)ETHANE-1,2-DIAMINE DIHYDROCHLORIDE
3-iodo-4-(4-propan-2-ylpiperazin-1-yl)benzoic acid
4-[(4-ethylpiperazin-1-yl)methyl]-3-iodobenzoic acid
methyl 3-iodo-4-[(3-methylpiperazin-1-yl)methyl]benzoate
N-(4-Chlorobenzyl)-N-Methylbenzene-1,4-Disulfonamide
Gavestinel
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D018377 - Neurotransmitter Agents > D018684 - Glycine Agents
3,,4-Dihydro-2-(3-methoxyphenyl)-2h-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide
N-[2-[[3-chloro-5-(triluoromethyl)pyridin-2-yl]methylsulanyl]ethyl]benzamide
ethyl (2Z)-5-phenyl-2-(1,1,1-trifluoro-3-methoxy-3-oxopropan-2-ylidene)-1,3-oxathiole-4-carboxylate
4-Fluorobenzoic acid 4-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)thio]but-2-ynyl ester
N-[(5-bromo-8-hydroxy-7-quinolinyl)-(2-furanyl)methyl]propanamide
3-(3-bromophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one
1-[[2-(1,3-Benzothiazol-2-ylthio)-1-oxoethyl]amino]-3-phenylthiourea
2-(4-Chlorophenyl)-6-(phenacylthio)-2,3-dihydrothiopyran-4-one
2-(8,9-Dimethyl-thieno[3,2-e][1,2,4]triazolo[4,3-c]pyrimidin-3-ylsulfanyl)-N-(5-methyl-isoxazol-3-yl)-acetamide
Methyl 3-[2-(2,6-dichlorophenyl)quinolin-6-yl]alaninate
1-S-[(1Z)-N-(sulfonatooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose
N-hydroxy-2-(4-iodopyrazol-1-yl)-6-methylsulanylbenzenecarboximidamide
glucocochlearin(1-)
An alkylglucosinolate that is the conjugate base of glucocochlearin.
isobutylglucosinolate
An alkylglucosinolate that is the conjugate base of isobutylglucosinolic acid.
butylglucosinolate
An alkylglucosinolate that is the conjugate base of butylglucosinolic acid.
Fatostatin (hydrobromide)
Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice[1][2].
Gavestinel
Gavestinel (GV 150526) is a selective and potent the glycine site of the NMDA receptor antagonist. Gavestinel has neuroprotectant effects[1].
